United States prepares broader tariff strategy as new trade measures take effect

Wednesday 22 July 2026 - 11:30

By: Sahili Aya

United States prepares broader tariff strategy as new trade measures take effect

The United States is preparing to expand its tariff strategy by introducing new import duties targeting several of its major trading partners, signaling that higher tariffs are set to remain a central feature of the country's trade policy.

The expected announcement follows the implementation of additional 25% tariffs on selected imports from Brazil, which came into force after a U.S. trade investigation concluded that certain Brazilian practices had unfairly restricted access for American exporters.

According to Jamieson Greer, the United States Trade Representative (USTR), the measures are intended to address trade practices that Washington believes have disadvantaged U.S. businesses by limiting access to one of their important export markets. The current tariff package applies to roughly half of Brazilian imports into the United States, representing an estimated $11 billion in traded goods.

The new tariffs form part of a broader effort by the administration to reshape trade relationships through the increased use of import duties. Officials have indicated that similar measures affecting other major trading partners are expected to be announced in the near future, although details on the countries and products involved have not yet been released.

The latest developments come several months after earlier U.S. tariff measures were struck down by the Supreme Court, prompting the administration to pursue revised legal mechanisms for imposing trade restrictions. The new approach is designed to strengthen the legal foundation of future tariff actions while maintaining pressure on countries that Washington believes engage in unfair commercial practices.

In a separate move, President Donald Trump announced new tariffs on imported generic medicines. Under the proposed schedule, these products will face a 100% import duty beginning in August 2028, with the rate scheduled to increase to 200% in 2029. The measure reflects the administration's broader objective of encouraging domestic manufacturing in strategic industries, including pharmaceuticals.

The expanding tariff agenda highlights the administration's continued reliance on trade policy as both an economic and geopolitical tool. While supporters argue that higher tariffs can strengthen domestic production and improve negotiating leverage, critics warn they may increase costs for businesses, disrupt global supply chains and contribute to higher consumer prices.

As additional tariff announcements are expected in the coming weeks, international trading partners and financial markets will be closely monitoring Washington's next steps and the potential implications for global commerce.